FDA Issues Nationwide Recall of Soaps Over ‘Life-Threatening Sepsis’ Risk

The U.S. Food and Drug Administration (FDA) has announced a nationwide voluntary recall of several soap products over fears they may be contaminated with dangerous bacteria.

DermaRite Industries is pulling Dermakleen, Dermasarra, and KleenFoam skin cleansers from shelves due to the presence of Burkholderia cepacia complex (Bcc), a pathogen that can cause life-threatening infections in vulnerable individuals.

Distributed nationwide to hospitals, nursing homes, and consumers, these products may pose a significant health risk.

Recall Products

The affected items are Dermakleen, Dermasarra, and KleenFoam skin cleansers, manufactured by DermaRite Industries. They were distributed nationwide between August 2, 2023, and August 1, 2024. These products are commonly used in healthcare facilities as part of patient hygiene routines, increasing the potential exposure risk among already vulnerable populations.

Reason for the Recall

Testing revealed potential contamination with Burkholderia cepacia complex (Bcc), a group of bacteria found in soil and water. While often harmless to healthy people, Bcc can cause severe infections, particularly in those with chronic lung disease or weakened immune systems.

Health Risks Involved

The most concerning complication linked to Bcc is sepsis, a potentially fatal condition where the body’s immune response spirals out of control. Infections may also lead to pneumonia or other respiratory issues. In healthcare settings, such infections can spread quickly and prove resistant to treatment.

How Bcc Spreads

Bcc can enter the body through open wounds, catheters, or by inhalation. Contaminated hygiene products are especially risky because they come in direct contact with the skin or mucous membranes. If applied to broken skin, the bacteria can bypass the body’s natural defenses.

FDA and Manufacturer Actions

The recall was initiated voluntarily by DermaRite Industries in coordination with the FDA. Both parties have urged healthcare facilities and consumers to stop using the products immediately and return them to the place of purchase. No injuries or illnesses have been reported so far, but the recall is a precautionary measure.

How to Identify Affected Products

Consumers can find lot numbers and expiration dates on the packaging. The recall applies to specific production batches listed on the FDA’s website. If unsure, consumers are advised to err on the side of caution and dispose of the product safely.

Past Incidents with Bcc Contamination

This isn’t the first time Bcc has triggered a recall. In recent years, similar bacteria-related recalls have affected wound washes, nasal sprays, and even hand sanitizers. Such cases highlight the persistent challenge of keeping personal care products free from microbial contamination.

What Consumers Should Do Next

Stop using the recalled soaps immediately, especially if you or someone in your household is immunocompromised. Report any signs of infection, such as fever, chills, shortness of breath, or unusual skin irritation, to a healthcare provider. The FDA also encourages filing a report through its MedWatch program to help track potential outbreaks.

Final Takeaway

While no illnesses have been linked to the recalled soaps yet, the risk posed by Burkholderia cepacia is significant enough to warrant swift action. Vulnerable individuals, especially those in healthcare settings, should be particularly cautious.

The incident is a reminder that even everyday hygiene products can become a health hazard if contaminated. Staying alert to recalls and practicing safe hygiene habits can make all the difference in preventing dangerous infections.